Using genetic information to personalize medication and treatment decisions
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
This study is looking at how your unique genes can help doctors choose the best treatments and preventions for you, and it's designed for patients who want more personalized care based on their genetic makeup.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10459256 on NIH RePORTER |
What this research studies
This research focuses on utilizing genomic variations to enhance therapeutic, preventative, and diagnostic decision-making in clinical care. It aims to overcome barriers to the adoption of personalized medicine by establishing a network of diverse health systems that can efficiently recruit patients and provide actionable insights to healthcare providers. The study will involve pragmatic clinical trials that assess the utility of pharmacogenomics testing and develop tools to identify patients at risk for genomic conditions. By integrating these approaches, the research seeks to improve patient outcomes through tailored treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are undergoing treatment for conditions that may be influenced by genetic factors.
Not a fit: Patients with conditions that are not related to genetic variations or those who do not require pharmacogenomic testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment plans for patients based on their genetic makeup.
How similar studies have performed: Previous research has shown promising results in the field of pharmacogenomics, indicating that personalized medicine approaches can significantly improve treatment outcomes.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Peterson, Joseph F. — Vanderbilt University Medical Center
- Study coordinator: Peterson, Joseph F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.